Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10XB-101 in bilateral flank adiposity
NCT05760248Phase 2Completed
- Sponsor
- 10xBio
- Start
- May 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 10XB101, sponsored by 10xBio. Started May 2023; status: completed.
02
Drugs
10XB101
Beyond the preview
Go deeper on NCT05760248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05760248.